文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

COVID-19 中的细胞因子风暴:从病毒感染到免疫反应、诊断和治疗。

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.

机构信息

Center of Reproduction, Development & Aging, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China.

Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

出版信息

Int J Biol Sci. 2022 Jan 1;18(2):459-472. doi: 10.7150/ijbs.59272. eCollection 2022.


DOI:10.7150/ijbs.59272
PMID:35002503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8741849/
Abstract

The COVID-19 outbreak is emerging as a significant public health challenge. Excessive production of proinflammatory cytokines, also known as cytokine storm, is a severe clinical syndrome known to develop as a complication of infectious or inflammatory diseases. Clinical evidence suggests that the occurrence of cytokine storm in severe acute respiratory syndrome secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is closely associated with the rapid deterioration and high mortality of severe cases. In this review, we aim to summarize the mechanism of SARS-CoV-2 infection and the subsequent immunological events related to excessive cytokine production and inflammatory responses associated with ACE2-AngII signaling. An overview of the diagnosis and an update on current therapeutic regimens and vaccinations is also provided.

摘要

COVID-19 疫情的爆发给公共卫生带来了巨大的挑战。细胞因子风暴,即过度产生促炎细胞因子,是一种已知的感染或炎症疾病的严重并发症。临床证据表明,由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染引起的严重急性呼吸综合征中细胞因子风暴的发生与重症病例的快速恶化和高死亡率密切相关。在这篇综述中,我们旨在总结 SARS-CoV-2 感染的机制,以及与 ACE2-AngII 信号相关的过度细胞因子产生和炎症反应的后续免疫事件。还提供了诊断概述以及当前治疗方案和疫苗接种的最新情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/8741849/50d8c438f005/ijbsv18p0459g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/8741849/1ac16e5acd8d/ijbsv18p0459g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/8741849/50d8c438f005/ijbsv18p0459g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/8741849/1ac16e5acd8d/ijbsv18p0459g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e3/8741849/50d8c438f005/ijbsv18p0459g002.jpg

相似文献

[1]
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.

Int J Biol Sci. 2022

[2]
An enlightening role for cytokine storm in coronavirus infection.

Clin Immunol. 2021-1

[3]
The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.

Int Immunopharmacol. 2021-6

[4]
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.

Clin Microbiol Rev. 2021-5-12

[5]
Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID-19 Cytokine Storm.

Adv Mater. 2021-5

[6]
A Review on Role of Inflammation in Coronavirus Disease.

Endocr Metab Immune Disord Drug Targets. 2024

[7]
A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.

Trends Mol Med. 2020-9-30

[8]
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.

Eur J Immunol. 2021-5

[9]
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.

Cytokine. 2021-2

[10]
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.

Front Immunol. 2021

引用本文的文献

[1]
Hematologic and Immunologic Overlap Between COVID-19 and Idiopathic Pulmonary Fibrosis.

J Clin Med. 2025-7-24

[2]
A feedback loop between DNA damage, genomic instability, and cytoplasmic DNA sensing contributes to cytokine production in COVID-19.

Arch Virol. 2025-8-11

[3]
Targeting ZBP1-Mediated PANoptosis: Inflammation-Responsive Selenized Chitosan Nanoparticles Loaded with Moringa A for Antiviral Pneumonia Therapy.

Biomater Res. 2025-8-5

[4]
Association between Guillain-Barré syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease.

J Neurovirol. 2025-7-7

[5]
The relationship between ferroptosis and respiratory infectious diseases: a novel landscape for therapeutic approach.

Front Immunol. 2025-3-18

[6]
Cognitive Sequelae of COVID-19: Mechanistic Insights and Therapeutic Approaches.

CNS Neurosci Ther. 2025-3

[7]
miR-27a-5p, miR-21-5p, miR-1246 and miR-4508: a candidate microRNA signature in the protection and regulation of viral infection in mild COVID-19.

Mol Med. 2025-3-15

[8]
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.

Front Immunol. 2025-2-12

[9]
RIP kinases and necroptosis in aging and aging-related diseases.

Life Med. 2022-6-14

[10]
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab.

J Transl Med. 2025-1-26

本文引用的文献

[1]
Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India.

Diabetes Metab Syndr. 2021

[2]
Vaccine Hesitancy: Drivers and How the Allergy Community Can Help.

J Allergy Clin Immunol Pract. 2021-10

[3]
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.

Curr Med Sci. 2021-12

[4]
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19.

CJC Open. 2021-10

[5]
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

N Engl J Med. 2021-7-15

[6]
Vaccine hesitancy in the era of COVID-19.

Public Health. 2021-5

[7]
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.

Lancet. 2021-5-15

[8]
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

N Engl J Med. 2021-6-10

[9]
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.

N Engl J Med. 2021-6-10

[10]
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

N Engl J Med. 2021-6-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索